Amyotrophic lateral sclerosis and frontotemporal lobar degeneration are two ends of a phenotypic spectrum of disabling, relentlessly progressive and ultimately fatal diseases. A key characteristic of both conditions is the presence of TDP-43 (encoded by TARDBP) or FUS immunoreactive cytoplasmic inclusions in neuronal and glial cells. This cytoplasmic mislocalization of otherwise predominantly nuclear RNA binding proteins implies a perturbation of the nucleocytoplasmic shuttling as a possible event in the pathogenesis. Compromised nucleocytoplasmic shuttling has recently also been associated with a hexanucleotide repeat expansion mutation in C9orf72, which is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal lobar degeneration, and leads to accumulation of cytoplasmic TDP-43 inclusions. Mutation in C9orf72 may disrupt nucleocytoplasmic shuttling on the level of C9ORF72 protein, the transcribed hexanucleotide repeat RNA, and/or dipeptide repeat proteins translated form the hexanucleotide repeat RNA. These defects of nucleocytoplasmic shuttling may therefore, constitute the common ground of the underlying disease mechanisms in different molecular subtypes of amyotrophic lateral sclerosis and frontotemporal lobar degeneration. 
Introduction
Many different mechanisms have been proposed as the root cause of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). These mechanisms have been shown to act at the molecular, cellular and systemic levels and include oxidative stress, excitotoxicity, mitochondrial damage, perturbed axonal transport, immunocytotoxicity, protein misfolding and aggregation. Pathological hallmarks of the overwhelming majority of ALS and over 50% of FTLD cases are cytoplasmic aggregation and nuclear clearance of transactive response DNAbinding protein (TDP-43, encoded by TARDBP), thus defining these diseases as TDP-43 proteinopathies. Fiftyseven per cent of Alzheimer's disease cases also involve confirmed TDP-43 proteinopathies (Josephs et al., 2014) . Cytoplasmic aggregates of a similar protein, FUS, are found in 5% of familial ALS and up to 10% of FTLD (Kwiatkowski et al., 2009; Neumann, et al., 2009a; Vance et al., 2009) . TDP-43 and FUS are predominantly nuclear proteins with DNA and RNA binding properties involved in regulating transcription, splicing, miRNA biogenesis and RNA transport (Buratti and Baralle, 2008; Ayala et al., 2011; Polymenidou et al., 2011; Tollervey et al., 2011; Rogelj et al., 2012; Ling et al., 2013) . ALSlinked mutations in TDP-43 account for up to 5% of all familial and 1-5% of sporadic ALS cases and, in FUS, for 5% of familial ALS and 51% of sporadic ALS cases, while mutations in either are rare in FTLD (Sreedharan et al., 2008; Kwiatkowski et al., 2009; Neumann, et al., 2009a; Mackenzie et al., 2011; Ling et al., 2013) . One of the important questions in this field is what makes TDP-43 or FUS mislocalize and aggregate. The answer lies in the changes in their de novo expression, nucleocytoplasmic shuttling and/or degradation. These changes may also arise from other disease-causing mutations, principal among which is the TDP-43 proteinopathy associated hexanucleotide repeat expansion (HRE) mutation in C9orf72 (DeJesus-Hernandez et al., 2011; Renton et al., 2011; Gijselinck et al., 2012) .
Irregularity of the nuclear envelope contour has been observed in ALS motor neurons in post-mortem spinal cords (Kinoshita et al., 2009 ) and a number of studies have highlighted the significance of nuclear transport impairment of FUS and TDP-43 in ALS and FTLD. This has been further substantiated by recent reports showing impairment of nucleocytoplasmic transport associated with the C9orf72 HRE mutation (Freibaum et al., 2015; Jovičić et al., 2015; Zhang et al., 2015 Zhang et al., , 2016 Boeynaems et al., 2016) . Here, we aim to provide an overview of nuclear transport and its involvement in the disease processes leading to ALS and FTLD. We will first cover FUS, as its mutations and modifications are highly indicative of the disturbance in nuclear transport. This will be followed by TDP-43, which, although prominent in both diseases, has not been studied sufficiently in terms of the nuclear transport. In the last section, we will discuss the nuclear transport pathomechanisms of the C9orf72 HRE mutation, which provide the first mechanistic link between TDP-pathology and HRE mutation.
Nuclear transport
Transport of molecules between the cytoplasm and the nucleus proceeds through the nuclear pore. Vertebrate nuclear pore complexes are large 125 MDa multiprotein assemblies of 30 distinct nucleoporins (NUPs) that span the nuclear envelope (Cronshaw et al., 2002; Floch et al., 2014) . Ions and small molecules diffuse passively in and out of the nucleus, while cargoes 440 kDa are actively transported through the nuclear pore and require energy in the form of GTP or ATP. A number of nuclear transport factors facilitate nucleocytoplasmic trafficking, many of which belong to the karyopherin-b (KPNB) family (Kutay et al., 1997; Chook and Sü el, 2011; Marfori et al., 2011) . KPNBs, also called importins and exportins, recognize the nuclear localization signal (NLS) and/or the nuclear export signal on protein cargoes, directly or through an adaptor protein, and localize them accordingly (see Cautain et al., 2015 for a comprehensive review). Translocation through the nuclear pore occurs by direct and transient binding of KPNBs to phenylalanine-glycine repeats in nucleoporins (Kahms et al., 2009) . Some proteins, however, are able to enter and exit the nucleus independently of the nuclear receptor pathways (Marfori et al., 2011; Cautain et al., 2015) .
A gradient of the small GTPase protein RAN drives and regulates the directionality of nuclear transport ( Fig. 1) . High nuclear levels of RAN-GTP are maintained by RCC1, which promotes exchange of GDP for GTP on RAN. On the cytoplasmic side RANGAP (RAN GTPase activating protein), together with RANBP1 or RANBP2, catalyses the hydrolysis of RAN-bound GTP, leading to higher levels of cytoplasmic RAN-GDP (Bischoff et al., 1995; Mahajan et al., 1997) . In the cytoplasm, importassociated KPNBs bind the NLS on the cargo or cargo complex and then translocate across the nuclear pore complex into the nucleus. In the nucleus, RAN-GTP binds to import-associated KPNBs, leading to release of the cargo. Finally, KPNBs, in a complex with RAN-GTP, are recycled back to the cytoplasm, where GTP is hydrolysed to GDP causing the dissociation of RAN from KPNBs. Conversely, nuclear export KPNBs bind the cargo's nuclear export signal and RAN-GTP to translocate to the cytoplasm. Immediately after GTP hydrolysis cargo is released in the cytoplasm, while nuclear export KPNBs and RAN-GDP are recycled back into the nucleus (Gö rlich, 1998; Nakielny and Dreyfuss, 1999; Pemberton and Paschal, 2005; Soniat and Chook, 2015) .
Of the 20 human KPNBs, 11 are involved in nuclear import (Soniat and Chook, 2015) . To date, four different types of NLSs have been identified and, for many karyopherins, the method of cargo recognition still remains to be elucidated (Soniat and Chook, 2015) . Importantly, cargoes can use one or several different nuclear import pathways, just as nuclear transport receptors can traffic many different cargoes. In the classical pathway, which is used by about half of the imported human proteins, adaptor proteins KPNAs bind to the classical NLS on the cargo that consists of one or two stretches of basic amino acids (monopartite or bipartite NLS, respectively) (Chook and Sü el, 2011) . KPNB1 then binds the KPNA-cargo complex and the tripartite complex transfers into the nucleus, where it dissociates following RAN-GTP binding to KPNB1. KPNB1 is recycled back to the cytoplasm in complex with RAN-GTP, while KPNAs are returned to the cytoplasm in a tripartite complex consisting of KPNA, RAN-GTP and CSE1L ( Fig. 1) (Kutay et al., 1997) . In some cases, cargo proteins bind directly to KPNB1 for translocation to the nucleus (reviewed in Marfori et al., 2011) . A group of RNA-binding proteins has another type of NLS with the R/H/KX 2-5 PY (PY-NLS) consensus sequence and they are directly bound by and imported into the nucleus with TNPO1 (transportin-1, KPNB2A) or TNPO2 (transportin-2 KPNB2B) ( Fig. 1) (Nakielny et al., 1996; Lee et al., 2006; Twyffels et al., 2014) . Nuclear export of proteins containing leucine-rich nuclear export signal is facilitated by another member of the KPNB family, CRM1 (also known as exportin 1, encoded by XPO1) (Fukuda et al., 1997; Ossareh-Nazari et al., 1997; Stade et al., 1997) . On binding to RAN-GTP, CRM1 transfers the cargo to the cytoplasm (Fig. 1) .
Nuclear export of mature mRNA occurs via two pathways by translocation of mRNA/protein complexes (mRNPs) through nuclear pore complex. The major export pathway for mRNPs involves the heterodimer NXF1 and its cofactor p15 (NXT1). CRM1 can also be recruited by a range of adaptor proteins to export a minor subset of mRNAs as well as rRNAs and U snRNAs (Kö hler and Hurt, 2007; Cautain et al., 2015) . In NXF1/NXT1 export mRNPs are labelled by one of two multi-protein complexes, most commonly TREX and TREX-2 (reviewed in Delaleau and Borden, 2015; Wickramasinghe and Laskey, 2015) . For NXF1/NXT1-mediated mRNA export, the most common adaptor is ALYREF. After forming, the mRNA, TREX, ALYREF, NXF1/NXT1 multi-protein complex translocate to the nuclear pore complex. Association of the mature mRNPs with NXF1 allows docking with the nuclear basket nucleoporins and subsequent translocation (1) and is powered by a gradient of the small GTPase protein RAN. High nuclear levels of RAN-GTP are maintained by RCC1, which promotes exchange of GDP for GTP on RAN (2). In the nucleus, RAN-GTP binds to KPNB1, leading to the release of the cargo (3). KPNB1, in a complex with RAN-GTP, is recycled back to the cytoplasm (4), while KPNAs are returned to the cytoplasm in a tripartite complex of KPNA, RAN-GTP and CSE1L (5). On the cytoplasmic side RANGAP, together with RANBP1 (or RANBP2, which is bound to the cytoplasmic side of the nuclear pore complex, NPC, but not shown here), catalyses the hydrolysis of RAN-bound GTP (6). This causes the dissociation of RAN from KPNB1 (7) or KPNA and CSE1L (8) . Some proteins are transported to the nucleus via a non-classical pathway mediated by TNPO1. TNPO1 carries cargoes through nuclear pore into the nucleus (9), where RAN-GTP binding on TNPO1 causes release of the cargo (10). TNPO1-RAN-GTP complex is exported into the cytoplasm (11), where RANGAP, together with RANBP1 (or RANBP2, not shown), catalyses the hydrolysis of RAN-bound GTP, leading to its dissociation from TNPO1 (12). Protein export is mediated by cooperative association in the nucleus of RAN-GTP, nuclear export signal-containing cargo and a karyopherin CRM1 (13). On the cytoplasmic side, hydrolysis of GTP bound to RAN results in dissociation of the complex and delivery of the cargo to the cytoplasm (14). In the nucleus mRNAs are bound by RNAbinding proteins forming mRNPs, which are labelled for export by transcription-export complexes (TREX) (15). Dissociation of protein components from mRNPs is mediated by DBP5 (16). GLE1 acts in concert with the InsP 6 to stimulate ATP hydrolysis by DBP5 on the cytoplasmic side of the nuclear pore complex, in turn releasing mRNA and proteins (17).
through the central channel. NXF1/NXT1 mediated export is driven by ATP. Namely, ATP-dependent helicase DBP5 interacts with GLE1 and inositol hexakisphosphate (InsP 6 ), which triggers the ATPase activity of DBP5 to catalyse the release of cargo mRNAs from the receptors ( Fig. 1) (Tseng et al., 1998; Alcá zar-Romá n et al., 2006; Weirich et al., 2006) .
FUS and other FET proteins
FUS is a member of the highly conserved FET protein family, which also contains EWSR1 and TAF15. At their extreme C-terminus they have a homologous PY-NLS, which interacts with TNPO1 or TNPO2 and leads to their nuclear import ( Fig. 2) (Lee et al., 2006; Zakaryan and Gehring, 2006; Dormann et al., 2010; Marko et al., 2012) . Mutations in the gene encoding FUS are the cause of 5% of familial ALS (ALS-FUS) (Kwiatkowski et al., 2009; Vance et al., 2009; Ling et al., 2013) . The majority of ALSassociated FUS mutations are missense mutations that result in single amino acid substitutions within the C-terminal NLS. This leads to impaired TNPO1 binding and, consequently, to cytoplasmic accumulation of FUS (Bosco et al., 2010; Dormann et al., 2010; Gal et al., 2011; Zhang et al., 2012; Vance et al., 2013) . As the severity of nuclear import block and cytoplasmic mislocalization of individual mutations correlates with the age of disease onset and its progression, nuclear import impairment appears to be a key event in the mechanism of ALS-FUS (Bosco et al., 2010; Dormann et al., 2010; Niu et al., 2012; Zhang et al., 2012 ). An additional requirement may be an agerelated increase in cell stress. Several forms of cell stress have been shown to lead to formation of FUS-positive stress granules, which are believed to be precursors of insoluble aggregates in the cytoplasm. Prolonged cell stress may cause growth and coalescence of the granules, giving rise to cytoplasmic inclusions (Bosco et al., 2010; Dormann et al., 2010; Gal et al., 2011; Vance et al., 2013) . Consequently, cytoplasmic inclusions in the affected neuronal and glial cells of ALS-FUS patients are TDP-43-negative and FUS-positive, often accompanied by reduced nuclear FUS staining (Kwiatkowski et al., 2009; Vance et al., 2009; Blair et al., 2010; Rademakers et al., 2010; Mackenzie et al., 2011) . ALS-linked FUS mutants do not sequester EWS and TAF15 or TNPO1 to FUS inclusions, indicating that ALS-FUS is restricted to reduced interaction of FUS with TNPO1 (Neumann et al., 2011) .
Cytoplasmic FUS inclusions co-localize with stress granule markers in FTLD-FUS post-mortem tissue as well (Dormann et al., 2010) . Importantly, it has been shown that several nuclear transport factors, such as KPNA1, KPNA4, KPNA5, KPNB1 and GLE1, are recruited to stress granules after exposure to cell stress, which may further disrupt nucleocytoplasmic shuttling (Mahboubi et al., 2013; Aditi et al., 2015a) . Their localization in inclusion bearing cells in ALS-FUS and FTLD-FUS post-mortem tissue still needs to be examined.
In contrast to ALS-FUS, FTLD-FUS cases are rarely associated with mutations in FUS, which makes the reason for FUS mislocalization to the cytoplasm unclear (Neumann et al., 2009a, b; Urwin et al., 2010; Lashley et al., 2011; Snowden et al., 2011) . Another hallmark difference between ALS-FUS and FTLD-FUS is the exclusive presence of FUS homologues, EWSR1 and TAF15, and the nuclear import factor TNPO1, in the FTLD-FUS inclusions (Brelstaff et al., 2011; Neumann et al., 2011 Neumann et al., , 2012 Davidson et al., 2013; Troakes et al., 2013) . All three FET proteins and TNPO1 show reduced nuclear staining in the inclusion bearing cells and a shift towards the insoluble fraction. This implies a more global defect of nuclear import in mechanism of FTLD-FUS. The regulation of nucleocytoplasmic transport can occur in several stages, from the most global, at the level of the nuclear pore complex, through intermediate, at the level of karyopherins, to the most specific, at the level of the cargo (Terry et al., 2007; Twyffels et al., 2014) . However, the normal subcellular distribution of 13 additional TNPO1 cargo proteins (HNRNPA1, SAM68, PABPN1 etc.) in FTLD-FUS cases, argues against general dysfunction of TNPO1-mediated import (Neumann et al., 2012) . On the other hand, a variety of post-translational modifications of FET proteins could affect their interaction with TNPO1 and lead to their cytoplasmic redistribution. Indeed, FET proteins can be asymmetrically dimethylated on arginine residues in RGG3 domain adjacent to the NLS, which reduces the strength of the interaction between FUS and TNPO1 (Rappsilber et al., 2003; Araya et al., 2005; Hung et al., 2009; Jobert et al., 2009; Dormann et al., 2012; Tradewell et al., 2012; Yamaguchi and Kitajo, 2012; Scaramuzzino et al., 2013; Suá rez-Calvet et al., 2016) . In ALS-FUS, FUS remains dimethylated while in FTLD-FUS cases, FUS inclusions are either monomethylated or unmethylated. Reduced methylation of FET proteins can result in enhanced binding of TNPO1 and thus explain the co-deposition of FET proteins and TNPO1 in FTLD-FUS inclusions (Dormann et al., 2012; Suá rez-Calvet et al., 2016) . However, inhibition of methylation in HeLa cells and primary neurons did not cause cytoplasmic accumulation of FUS, arguing against hypomethylation as the only cause for cytoplasmic mislocalization of FUS in FTLD-FUS (Dormann et al., 2012) . The mechanism leading to hypomethylation of FET proteins in FTLD-FUS cases is still unknown. There is no evidence for mutations (Ravenscroft et al., 2013) or reports of deficiency in PRMT activity in FTLD-FUS cases. However, out of nine PRMTs only PRMT1, PRMT3 and PRMT8 have been genetically screened so far (Ravenscroft et al., 2013) .
Phosphorylation can also play a role in FUS mislocalization. It has been shown that the C-terminal tyrosine residue at position 526 of FUS can undergo phosphorylation, which abolishes interaction of FUS with TNPO1 and, consequently, affects its nuclear import .
Phosphorylation of C-terminal tyrosine residue at position 656 has also been reported in EWSR1 (Leemann- Zakaryan et al., 2011) . While, under physiological conditions, phosphorylation may serve in fine tuning the nuclear-cytoplasmic shuttling of FET proteins, increased or decreased phosphorylation of C-terminal tyrosine residue could lead to their cytoplasmic mislocalization and aggregation. However, the physiological and pathological roles of this phosphorylation in ALS-FUS and FTLD-FUS still remain to be determined.
TDP-43
Like FUS, TDP-43 is predominantly nuclear, with low levels of protein also present in the cytoplasm. However, in the majority of ALS and over 50% of patients with FTLD there is a pathognomonic redistribution of TDP-43 from the nucleus into the cytoplasmic inclusions of the affected neurons, where TDP-43 is ubiquitinated, phosphorylated and partially cleaved (Neumann et al., 2006; Kwong et al., 2007; Mackenzie et al., 2011; Sieben et al., 2012; Ling et al., 2013) . Mutations in the TARDBP gene encoding TDP-43 are present in only 1-5% of the familial and sporadic ALS cases, leaving the cause for the accumulation and aggregation of the wild-type protein unexplained. Recent papers have connected molecular events arising from the C9orf72 mutation with perturbation of the nuclear transport and a downstream effect on TDP-43 mislocalization. This will be covered in detail in the section on C9ORF72.
Translocation of TDP-43 into the nucleus is an active process carried out by the KPNA/KPNB1 import pathway. the nucleus via a non-classical pathway mediated by interaction with TNPO1 (1). TNPO1 carries FUS through nuclear pore into the nucleus (2), where RAN-GTP binding on TNPO1 causes release of FUS (3). TNPO1-RAN-GTP complex is exported into the cytoplasm (4), where RANGAP, together with RANBP1 or RANBP2, catalyses the hydrolysis of RAN-bound GTP, leading to its dissociation from TNPO1 (5). In ALS-FUS cases NLS of FUS is mutated, which disrupts TNPO1 binding and its nuclear import (6). Consequently, FUS accumulates in cytoplasm, where, under cellular stress, it is recruited to stress granules (7). Mutated FUS binds unmutated FUS, causing its sequestration to stress granules (8). Nuclear import of EWSR1 and TAF15 is not affected in ALS-FUS (9). FUS is not mutated in FTLD-FUS and all three FET proteins and TNPO1 are co-localized in cytoplasmic inclusions (10). As FUS, EWSR1 and TAF15 share homologous NLS, presence or absence of a posttranslational modification might affect their nuclear transport and lead to their cytoplasmic mislocalization and reduced nuclear staining in FTLD-FUS (11). Nuclear import of other TNPO1 cargoes is not affected in FTLD-FUS (12). Proteins with reduced levels are in dashed outline.
All five tested KPNAs can bind TDP-43 having an intact NLS (Nishimura et al., 2010) . KPNB1 then binds to KPNA and the tripartite complex with TDP-43 is actively transported into the nucleus (Fig. 3) . Inside the nucleus, the complex dissociates following binding of RAN-GTP to KPNB1 and KPNB1-RAN-GTP is recycled directly back to the cytoplasm, while KPNAs require transport by a nuclear export factor CSE1L (also known as CAS), which is also bound to RAN-GTP. Knockdown of KPNB1 or CSE1L in cultured cells causes a reduction of KPNA recycling, leading to a significant accumulation and aggregation of TDP-43 in the cytoplasm. As levels of CSE1L and, to a lesser extent, KPNA2 are reduced in the brains of patients with FTLD-TDP, this might contribute to pathological mislocalization and aggregation of TDP-43 in FTLD-TDP cases (Nishimura et al., 2010) . No difference in CSE1L levels has been observed in ALS spinal cord tissue, but nuclear contour irregularity and loss of nuclear KPNB1 distribution in anterior horn cells of sporadic ALS cases suggests that abnormalities in nuclear transport are also associated with ALS (Kinoshita et al., 2009) .
Replacement of the basic residues in NLS with alanine or serine promotes cytoplasmic localization and aggregation of TDP-43 in primary neurons (Ayala et al., 2008; Winton et al., 2008) . The impact of the nuclear import perturbation on ALS pathology has been underlined in a mouse model, in which inducible expression of human TDP-43 with a deleted NLS (hTDP-43 ÁNLS) causes cytoplasmic accumulation of insoluble phosphorylated TDP-43 in mouse brain and spinal cord (Walker et al., 2015) . Importantly, suppression of hTDP-43 ÁNLS expression resulted in substantial clearance of TDP-43 pathology, prominent increase in muscle innervation and prolonged lifespan (Walker et al., 2015) .
TDP-43 is also found condensed in intranuclear inclusions, mainly in familial FTLD with VCP mutations, suggesting that a perturbation of nuclear export might also play some role in the disease (Neumann et al., 2006, into the nucleus by the classical import pathway. KPNAs bind the NLS of TDP-43 (1). KPNB1 then binds KPNA-TDP-43 complex in the cytoplasm and the tripartite complex is carried through nuclear pore into the nucleus (2). RAN-GTP binding in the nucleus causes dissociation of the complex and release of TDP-43 (3). KPNB1 is recycled back to the cytoplasm in a complex with RAN-GTP (4), while KPNAs are returned to the cytoplasm in a tripartite complex consisting of KPNA, RAN-GTP and CSE1L (5). In the cytoplasm RANGAP, together with RANBP1 (or RANBP2, not shown), catalyses the hydrolysis of RAN-bound GTP, leading to dissociation of KPNB1, KPNAs and CSE1L (6). Mutations in TDP-43 account for up to 5% of familial ALS, causing accumulation of mutated TDP-43 in cytoplasmic inclusions (7). In majority of ALS cases and over 50% of FTLD cases, non-mutated TDP-43 forms the cytoplasmic aggregates (8). Reduced levels of CSE1L in FTLD-TDP (9) and loss of nuclear KPNB1 in ALS-TDP (10) imply that this may be due to a nuclear transport defect. Proteins with reduced levels are in dashed outline.
2007). Indeed, TDP-43 carries a leucine-rich nuclear export signal located between amino acids 239 and 250, which enables its export from the nucleus to the cytoplasm (Winton et al., 2008) . Replacement of the hydrophobic residues in the nuclear export signal with alanine, prevents TDP-43 from exiting the nucleus and leads to the formation of intranuclear inclusions (Winton et al., 2008) . Heat-shock stress has also been shown to result in nuclear aggregation of TDP-43 (Udan-Johns et al., 2014).
Several studies have shown that TDP-43 levels have an impact on the nuclear transport, suggesting a potential feed-back regulation mechanism (Ward et al., 2014; Š talekar et al., 2015; Xiao et al., 2015) . TDP-43 knockdown in SH-SY5Y cells affects expression of proteins involved in nuclear transport, such as nuclear pore complex proteins NUP205, NUP160 and NUP153, mRNA export factor RAE1, RANBP1, exportin XPO1/CRM1, importins IPO7 and IPO5, calreticulin and nuclear envelope pore membrane protein POM121C (Š talekar et al., 2015) . Depletion of TDP-43 also leads to downregulation of RAN in N2A cells, and expression of non-functional RAN protein mutants in cortical neurons results in reduced TDP-43 nuclear localization (Ward et al., 2014) . As TDP-43 regulates expression of RAN protein by binding directly to the 3'-UTR region of its mRNA, depletion of nuclear TDP-43, followed by consequent downregulation of RAN, could lead to a progressive loss of TDP-43 from the nucleus (Ward et al., 2014) . Furthermore, expression of the aggregation-prone mutant TDP-43 can lead to cytoplasmic accumulation of the otherwise nuclear THOC2 (Woerner et al., 2016) . As THOC2 is a subunit of the mRNA export system, this may lead to a slowdown in the export of mRNAs.
Overall, the regulation of the nuclear transport machinery by TDP-43 raises a question as to whether initial modest TDP-43 mislocalization and aggregation can impair nuclear transport on its own and form a positive feedback loop, causing more TDP-43 to accumulate and aggregate in the cytoplasm.
C9ORF72, expanded repeat RNA and the dipeptide repeat proteins
The (G 4 C 2 ) n HRE mutation of the C9orf72 gene can span from several hundred to several thousand repeats, and is one of the main genetic causes of ALS and FTLD leading to TDP-43 proteinopathy (DeJesus-Hernandez et al., 2011; Renton et al., 2011; Cooper-Knock et al., 2014) . It accounts for up to 80% of familial ALS-FTLD, 20-50% of familial ALS, 5-20% of sporadic ALS and 10-30% of FTLD (reviewed in Ling et al., 2013) . Apart from influencing the expression of the C9ORF72 protein, the HRE RNA accumulates in the form of RNA foci that can sequester cellular RNA-binding proteins. Transcription of the antisense strand has also been observed, as well as formation of antisense RNA foci (Donnelly et al., 2013; Gendron et al., 2013; Mizielinska et al., 2013; Zu et al., 2013) . Furthermore, the repeat RNA can be translated via a repeat associated non-ATG translation mechanism, resulting in the accumulation of different dipeptide repeat proteins (DPRs): sense poly-glycine-alanine (GA), poly-glycineproline (GP) and poly-glycine-arginine (GR), and anti-sense poly-proline-arginine (PR), poly-glycine-proline (GP) and poly-proline-alanine (PA) (Gendron et al., 2013; Mori et al., 2013a, b; Zu et al., 2013; reviewed in Vatovec et al., 2014) . Inclusions of TDP-43 aggregates in brain and spinal cord are prevalent in the majority of patients carrying the repeat expansion, with some brain regions less commonly affected with the pathology (Al-Sarraj et al., 2011; Troakes et al., 2012; Schipper et al., 2015) . Recent studies show that all three hypothesized disease mechanisms, namely C9ORF72 haploinsufficiency, RNA toxicity, and DPR toxicity, may, either independently or concurrently, affect the nuclear transport process, also resulting in TDP-43 mislocalization and aggregation.
In support of the haploinsufficiency hypothesis, C9orf72 mRNA and C9ORF72 protein have been shown to be reduced in the frontal cortex of HRE mutation-carrying ALS and FTLD patients (Waite et al., 2014) , but the physiological role of C9ORF72 protein still remains to be resolved. Bioinformatic and recent biochemical analyses suggest that it is a homologue of DENN (differentially expressed in normal and neoplasia) proteins, which serve as GDP-GTP exchange factors for RAB-GTPases involved in RAB-dependent vesicular trafficking Levine et al., 2013; Farg et al., 2014) . The alternative splicing of C9orf72 can result in three transcripts (V1, V2 and V3) and, as two of the transcripts have the same open reading frame, translation of the variants yields two protein isoforms, short (24 kD) and long (54 kDa). Using specific antibodies against the long (C9-L) and short (C9-S) forms of C9ORF72, the latter was found at the nuclear membrane in healthy control spinal motor neurons, although, in ALS patients (HRE mutation positive and negative), it was localized to the plasma membrane (Fig. 4) (Xiao et al., 2015) . In addition, in spinal motor neurons of patients carrying the HRE mutation, the loss of C9-S from the nuclear membrane correlated with mislocalization of KPNB, RAN and TDP-43 (Fig. 4) (Xiao et al., 2015) . Furthermore, both isoforms have shown direct binding to KPNB1 and RAN (Xiao et al., 2015) , making the C9-S isoform of C9ORF72 protein a potential regulator of nucleocytoplasmic shuttling.
In two studies on different Drosophila models, a possible role for the sense repeat RNAs in the disturbances of nucleocytoplasmic trafficking has been identified (Table 1) (Freibaum et al., 2015; Zhang et al., 2015) . In the first study, the Drosophila orthologue of human RANGAP1 was shown to be a potential suppressor of neurodegeneration in flies expressing G 4 C 2 -repeats . RANGAP1 interacts with G 4 C 2 -repeats and can be sequestered by RNA foci. As a consequence, the RAN gradient is disturbed, resulting in impaired translocation of RNA and proteins through the nuclear pore complex. In induced pluripotent stem cell (iPSC) patient-derived neurons and in the motor cortex of C9orf72 patients RANGAP1 was shown to accumulate in cytoplasmic puncta, co-localizing with G 4 C 2 RNA and nuclear pore complex components NUP205 and NUP107 (Fig. 4) . Importantly, G 4 C 2 expression also led to cytoplasmic accumulation of TDP-43 in salivary gland cells of Drosophila and in C9orf72 patient iPSCderived neurons, suggesting impaired nuclear import as the root pathomechanism . Consistently, in a second Drosophila study, a dominantnegative form of RAN strongly enhanced the neurodegeneration in flies expressing G 4 C 2 (Freibaum et al., 2015) . In addition, components of the nuclear pore complex (NUP50, NUP153, TNPO1, NUP107, NUP160), the proteins involved in protein shuttling (NUP50, KPNB1, RAN, CRM1) and export of RNA (ALYREF, TREX complex, NXF1, cap-binding proteins NCBP1, NCBP2, and ARS2, NUP107, NUP160, GLE1, CRM1) were recognized as mediators or suppressors of G 4 C 2 facilitated neurodegeneration (Freibaum et al., 2015) .
Cells transiently expressing expanded G 4 C 2 repeats, as well as iPSC derived cortical neurons from patients with the C9orf72-related disease, show nuclear retention of their mRNAs (Freibaum et al., 2015; Rossi et al., 2015) . This nuclear retention may be driven by relocalization of PABPC1 from the cytoplasm to the nuclear foci (Fig. 4) (Rossi et al., 2015) . The mRNA retention can be suppressed with reduction or loss of Ref1, a Drosophila homologue of ALYREF (Freibaum et al., 2015) . ALYREF binds to the 5 0 end of mRNAs and prevents their degradation by the nuclear exosome. Together with another component of TREX complex, CHTOP, it also delivers the new mRNA to the nuclear pore receptor NXF1 which, in turn, mediates its RAN independent nuclear export (Zhou et al., 2000; Kö hler and Hurt, 2007; Viphakone et al., 2012; Chang et al., 2013) . On the other hand, loss of function of Figure 4 Model of the influence of C9ORF72, C9orf72 RNA and DPR on nucleocytoplasmic transport. The short isoform of C9ORF72 (C9-S) is localized at the nuclear membrane in healthy controls (1) while, in ALS patients, it is found at the plasma membrane (2). The loss of C9-S from the nuclear membrane correlates with the mislocalization of TDP-43, KPNB, and RAN (3). RNA-binding proteins (RBPs), cytoplasmic stress granule marker PABPC1 and RNAs are sequestered in nuclear RNA foci (4). Due to impaired RNA (5) and protein export (6), nuclear mRNA and protein levels are increased, and cytoplasmic RAN-GTP levels are increased (7). Some of the C9orf72 HRE mutationbearing RNA is transported to the cytoplasm, where it either accumulates and sequesters proteins involved in nucleocytoplasmic trafficking (8), or it is translated into DPR proteins (9). In turn, some of the DPR proteins aggregate and sequester nucleocytoplasmic transport related proteins (10). Recycling of CSE1L and KPNA, and part of RAN-GTP cycling have been removed from the left panel for simplicity. For details see GA/GP/GR/PR = glycine-alanine/glycine-proline/glycine-arginine/proline-arginine; NMJ = neuromuscular junction.
mRNA export factors CHTOP, NXF1 or GLE1 or RNA degradation factors EXOSC3 and EXOSC10 enhanced the rough eye phenotype in Drosophila (Freibaum et al., 2015) . Importantly, mutations in GLE1 and EXOSC3 have already been shown to result in foetal forms of motor neuron disease (Nousiainen et al., 2008; Wan et al., 2012) . Additionally, several GLE1 mutations have now been associated with ALS and one of these mutations leads to depletion of GLE1 from the nuclear pore (Aditi et al., 2015b; Kaneb et al., 2015) . This suggests a disease mechanism of toxic over-accumulation of mRNA in the nucleus due to reduction of clearance resulting from either deficient RAN independent mRNA export or deficient degradation. However, neither of the two initial Drosophila studies was set up to differentiate between RNA and DPR toxicity as the cause of the nuclear transport perturbation. Three recent papers on yeast, fruit fly and mouse models of DPRonly toxicity favour the DPRs (Table 1) (Jovičić et al., 2015; Boeynaems et al., 2016; Zhang et al., 2016) . Screening for modifiers of DPR toxicity in Saccharomyces cerevisiae has uncovered 11 modifiers involved in nucleocytoplasmic transport (Jovičić et al., 2015) . Six of them belong to the karyopherin family and their upregulation rescued the toxicity but did not impact DPR localization or levels. In agreement with one of the above Drosophila studies, the yeast homologue of human RCC1 was found to be an important regulator of DPR toxicity as its upregulation also enhanced PR toxicity (Jovičić et al., 2015; Zhang et al., 2015) . Furthermore, RCC1 was observed to be reduced in the nuclei of C9orf72 patient derived induced neurons, suggesting a reduction in RAN dependent nuclear transport (Jovičić et al., 2015) . Interestingly, RCC1-like GEF domains are also found in alsin whose mutations are associated with a juvenile form of ALS (Yamanaka et al., 2003) . As in yeast, DPR toxicity was linked to the perturbation of the protein equilibrium of nuclear pore complex proteins, importins, exportins, and regulators of the RAN-GTP cycle in Drosophila model (Boeynaems et al., 2016) . The strongest enhancement of PR-induced neurodegeneration was following knockdown of TNPO1 (Boeynaems et al., 2016) . The authors suggest a mechanism whereby PR repeats bind to TNPO1, thus replacing its cargoes and causing their mislocalization. This was validated in human C9orf72 HRE mutation positive brains, where cytoplasmic aggregation of the TNPO1 cargo HNRNPA3 was observed (Boeynaems et al., 2016) . An important question here is what happens to other TNPO1 cargoes, especially FUS, which has not been shown to aggregate in human C9orf72 HRE mutation-positive brains. Most recently, GA aggregates have been shown to sequester proteins involved in nucleocytoplasmic transport (Zhang et al., 2016) . GA aggregates co-localized mainly with nuclear pore complex proteins, RANBP1 and POM121, in abnormal cytoplasmic and nuclear punctae (Fig. 4) (Zhang et al., 2016) .
As the studies on C9ORF72 related to nuclear trafficking were conducted on different cell/animal models, following DPR and/or RNA toxicity, at this moment it is not possible to draw a line and give some generalized mechanism. Much more work is needed to decipher the involvement of different groups of modifiers of nucleocytoplasmic shuttling (i.e. RANGTPase cycle, nucleoporins, importins, exportins, etc) in the ALS and FTLD pathomechanism.
Conclusion
In the light of recent findings, components of the nuclear pore and of the nucleocytoplasmic transport machinery are clearly involved in C9ORF72-, TDP-43-, and FUS-associated ALS and FTLD. Thus, the age-related deterioration of nuclear-pore complexes, which lead to an increase in nuclear permeability, could play a key role in the development of these diseases (D'Angelo et al., 2009). Whether or not this process is accelerated in ALS/FTLD or is one of the key ageing-related deteriorations that enable the development of the disease, remains to be determined.
Several recent papers show that proteins with prion-like domains, including TDP-43, FUS and other HNRNPs, can undergo phase separation from soluble proteins to pureprotein liquid droplets in vitro Molliex et al., 2015; Murakami et al., 2015; Patel et al., 2015) . Over time proteins in these droplets start to aggregate and give rise to insoluble fibrillar structures. As these liquid droplets have stress granule-like properties, a stress granule origin of insoluble aggregates is further substantiated. With ageing-related perturbance in nucleocytoplasmic shuttling, is it possible that the increase in the cytoplasmic levels of these proteins beyond the carrying capacity of the cytoplasm, leads to phase separation, formation of liquid droplets/stress granules, followed by the formation and accumulation of the hallmark aggregates?
